Related Experiment Videos
[Oligodendrogliomas: historical background of classifications]
F Nataf1, M-L Tucker, P Varlet
1Service de Neurochirurgie, Centre Hospitalier Sainte-Anne, Paris. f.nataf@ch-sainte-anne.fr
Neuro-Chirurgie
|November 18, 2005
Summary
Glioma classifications have evolved from early histological methods to include molecular genetics and imaging data. Understanding these changes is crucial for accurate diagnosis and treatment of brain tumors.
Area of Science:
- Neuropathology
- Oncology
- Medical Imaging
Context:
- The classification of gliomas has historically relied on cytological and histological examination of brain tissue.
- Advancements in diagnostic techniques have progressively refined our understanding of central nervous system cell types and tumor characteristics.
Purpose:
- To review the historical development of glioma classification systems.
- To present key classifications, including those by Bailey and Cushing, Kernohan, the World Health Organization (WHO), and the Sainte-Anne system.
Summary:
- Early classifications (Bailey & Cushing, 1926) were based on histoembryogenetic theory, followed by Kernohan's concept of anaplasia (1938).
- The WHO classification, revised over time (1979, 1993, 2000), integrated histological malignancy criteria.
- Recent systems, like the Sainte-Anne classification for oligodendrogliomas, incorporate molecular genetics, clinical evolution, and imaging data, including spatial histological structure and contrast enhancement related to endotheliocapillary hyperplasia.
Impact:
- Recognizes the evolution of glioma classification, highlighting the integration of diverse data types.
- Addresses challenges in current classifications, such as reproducibility issues and misinterpretations, emphasizing the need for clarity.
- Underscores the dynamic nature of glioma classification, driven by technological and scientific advancements.